Medtech company Shoulder Innovations has commercially launched the InSet 70 Humeral Stem.
The new implant is indicated for anatomic and reverse shoulder arthroplasty procedures, according to a Sept. 22 news release from Shoulder Innovations.
Clinical needs that are addressed by the InSet 70 includes non-inflammatory degenerative joint disease and correction of functional deformity.
The commercial launch of the implant expands the company’s I-Series humeral stem product line, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.